<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Gary Delhougne

SmartTRAK GM, Wound. Licensed attorney with 20 years’ medical device and consulting experience in market access, health economics and policy roles at Smith & Nephew, Covidien, Avalere Health and Ernst & Young.

Wound Care

The Future is Today in Remote Patient Monitoring: An Interview with Scott Laster

Scott Laster, CEO and co-founder of MiCare Path, discusses the present and future of monitoring patients...

Wound Care

What's New in Wound Care Reimbursement 2022: An Interview w/ Kathleen Schaum

Kathleen “Kathy” Schaum, President of Kathleen D. Schaum & Associates, discusses her thoughts on the...

Wound Care

SmartTRAK’s 2022 Outlook for the US Skin Substitute/CTP Market

From Site of Care Migration to the Impact of Reimbursement Changes SmartTRAK evaluates market trends to ...

Wound Care

Continued Rebound: Q321 Advanced Wound Care Market Recap

Advanced Wound Care (AWC) continues to rebound in 2021 with growth from US Skin Substitutes and WW Advan...

Wound Care

SAWC Fall 2021 - The Return of In-Person Wound Care Conferences

Clinical and industry attendees return to in-person conferences but product launches were limited. It ha...